Suchergebnisse - "2494G1JF75"

PubPharm (1.795)

1

Population Pharmacokinetics of Pediatric Lopinavir/Ritonavir Oral Pellets in Children Living with HIV in Africa

enthalten in: Clinical pharmacology and therapeutics | 2024

von Chupradit, S. | Wamalwa, D. | Maleche-Obimbo, E. | +11

2

Safety and Pharmacokinetics of Lopinavir/Ritonavir Oral Solution in Preterm and Term Infants Starting Before 3 Months of Age

enthalten in: The Pediatric infectious disease journal | 2024

von Bekker, A. | Yang, J. | Wang, J. | +11

3

Physicochemical interaction of rifampicin and ritonavir-lopinavir solid dispersion : an in-vitro and ex-vivo investigation

enthalten in: Drug development and industrial pharmacy | 2024

von Nair, A. | Vullendula, S. | Yarlagadda, D. | +3

4

A detailed characterization of drug resistance during darunavir/ritonavir monotherapy highlights a high barrier to the emergence of resistance mutations in protease but identifies alternative pathways of resistance

enthalten in: The Journal of antimicrobial chemotherapy | 2024

von Abdullahi, A. | Diaz, A. | Fopoussi, O. | +5

5

Factors associated with the acceptability of Lopinavir/Ritonavir formulations among children living with HIV/AIDS attending care and treatment clinics in Mbeya and Mwanza, Tanzania

enthalten in: PloS one | 2024

von Jiwa, N. | Ketang'enyi, E. | Nganyanyuka, K. | +12

6

Paediatric abacavir-lamivudine fixed-dose dispersible tablets and ritonavir-boosted lopinavir granules in neonates exposed to HIV (PETITE study) : an open-label, two-stage, single-arm, phase 1/2, pharmacokinetic and safety trial

enthalten in: The lancet. HIV | 2024

von Bekker, A. | Salvadori, N. | Rabie, H. | +10

ErratumIn: Lancet HIV. 2024 Apr 5;:. - PMID 38588690

7

Prevalence and risk factors of metabolic syndrome in Ethiopia : describing an emerging outbreak in HIV clinics of the sub-Saharan Africa - a cross-sectional study

enthalten in: BMJ open | 2023

von Abdela, A. | Yifter, H. | Reja, A. | +3

8

Evaluating pediatric tuberculosis dosing guidelines : A model-based individual data pooled analysis

enthalten in: PLoS medicine | 2023

von Galileya, L. | Wasmann, R. | Chabala, C. | +11

9

Twenty-eight-day mortality among patients with severe or critical COVID-19 in Hong Kong during the early stages of the pandemic

enthalten in: Hong Kong medical journal = Xianggang yi xue za zhi | 2023

von Chan, A. | Lung, K. | Yu, J. | +2

10

Inadequate Lopinavir Concentrations With Modified 8-Hourly Lopinavir/Ritonavir 4:1 Dosing During Rifampicin-based Tuberculosis Treatment in Children Living With HIV

enthalten in: The Pediatric infectious disease journal | 2023

von Chabala, C. | Turkova, A. | Kapasa, M. | +113

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[180]